Home Blog Page 4

WellEra Introduces ‘Healthspan’ as a New Return on Investment in Wellness Real Estate

By
Advertorial Desk
-

As the global wellness real estate market is projected to reach USD 1.8 trillion by 2030, WellEra introduces a new perspective on residential investment—where value is measured not only by location, design and financial returns, but also by how well a home supports healthier, longer living. By integrating healthier indoor environments, circadian-friendly lighting, acoustic and thermal comfort, and healthcare support close at hand, WellEra brings “Healthspan” into the conversation around long-term property value—raising a new question: Can where we live become an investment in how well we live?

BANGKOK, THAILAND – Media OutReach Newswire – 8 September 2026 – The Global Wellness Real Estate market is entering a period of rapid expansion, reaching USD876 billion in 2025, up from USD246 billion in 2019, and forecast to reach USD1.8 trillion by 2030. Thailand is emerging as an important market within this trend, with its wellness economy valued at more than USD42.7 billion. Wellness Real Estate grew 22.9%, making it the country’s second-fastest-growing wellness sector.

WellEra_Healthspan as a New Investment Access_Infographic

For real-estate investors, location, capital appreciation, rental yield, price and lifestyle value remain fundamental. At the same time, as people increasingly seek longer, healthier lives, wellness-integrated properties are emerging as a new investment consideration, raising a question beyond financial returns: what can a property give back to the people who live there?

WellEra, developed by BDMS, introduces Healthspan as a new dimension of residential investment value. Rather than treating wellness as an added feature, WellEra brings BDMS Wellness Clinic’s expertise in Scientific Wellness, preventive healthcare and personalized health management into the built environment, creating an ecosystem designed for long-term health and quality of life.

Healthspan refers to the years a person lives in good health, free from chronic illness, disability or significant physical decline, while lifespan measures years lived. Globally, average lifespan is 71.4 years, compared with a healthspan of 61.9 years—a gap of nearly a decade. As people live longer, the focus is shifting from extending life alone to extending the years lived with strength, independence and quality of life.

“Scientific evidence shows that our health is shaped not only by genetics or medicine, but also by the environments we experience every day,” said Dr. Tanupol Virunhagarun, Chief Executive Officer – Group 8 (BDMS Wellness Clinic, BDMS Wellness Resort, BDMS Silver), Bangkok Dusit Medical Services Public Company Limited (BDMS). “The future of investment may not be defined solely by financial returns, but by the ability of our homes and communities to help us live longer, healthier, and better lives.”

WellEra translates this idea into the built environment through its 6S+ Surrounding framework, incorporating Air, Water, Light, Sound, and Thermal Comfort into residential design. Research has linked indoor air quality with cognitive function, light exposure with circadian rhythms and sleep, environmental noise with sleep and cardiovascular health, and indoor thermal conditions with health. WellEra applies these principles through MERV-14 air filtration with up to 95% efficiency in filtering PM2.5, advanced water filtration and UV treatment, circadian-friendly lighting with UGR ≤16, STC-60 acoustic systems and indoor relative humidity maintained at 50-65%. Healthcare Humanware Supported by BDMS further provides 24-hour nursing and medical support, personalized health management, and emergency services.

Together, these elements position WellEra beyond the conventional Wellness Real Estate model, where wellness often centers on amenities such as spas, gyms and green spaces. By integrating scientific wellness, healthcare and environmental design into everyday living, WellEra establishes a new benchmark for residential investment—measured not only by financial returns, but also by the life value created through healthier living, greater well-being and the opportunity to live well for longer.

please visit www.wellerabangkok.com.

Hashtag: #WellEra #BDMSWellnessClinic #Wellnessrealestate #TheDNAofWorldWellLiving #Living

The issuer is solely responsible for the content of this announcement.

Waterdrop Inc. Reports Second Quarter 2026 Unaudited Financial Results

By
Advertorial Desk
-

BEIJING, Sept. 8, 2026 /PRNewswire/ — On September 8, Waterdrop Inc. (NYSE: WDH) released its unaudited financial results for the second quarter ended June 30, 2026. In Q2 2026, the company’s operating revenue reached RMB1,448.2 million, up 72.8% year-over-year; net profit attributable to ordinary shareholders was RMB125.8 million, marking 18 consecutive quarters of profitability. As of August 31, 2026, the company had cumulatively repurchased approximately 62.9 million ADSs (American Depositary Shares) from the open market.

With solid performance in Q2, the company achieved rapid revenue growth. Going forward, Waterdrop will continue to increase investment in AI technology innovation, making healthcare and financial services more accessible to the public.

Insurance Business Grows Steadily, AI Penetration Continues to Rise

This quarter, the insurance business maintained strong growth, with insurance-related revenue up 80.5% year-over-year. Meanwhile, profitability continued to improve, with insurance business operating profit reaching RMB183.6 million, up 20% quarter-over-quarter. Waterdrop is comprehensively accelerating the application of AI technology across the entire insurance value chain. Premiums facilitated by ‘AI Medical Insurance Expert’ rose by 25.6% quarter-over-quarter. First-year premiums for long-term insurance grew 33.4% quarter-over-quarter.

In terms of product innovation, leveraging its massive claims data and user profile analytics, Waterdrop has broken the traditional static logic of blanket rejection for people with chronic diseases, removing barriers to coverage for users with pre-existing conditions one by one. This quarter, Waterdrop launched ‘Rongyibao,’ the market’s first long-term critical illness insurance product that requires no health disclosure and offers five-year guaranteed renewability, covering more than 100 critical illnesses with optional riders for accidental death and disability benefits. At the same time, the company expanded ‘Jixing Gaozhao’ series with the market’s first lifetime specified disease insurance product requiring no health disclosure.

Waterdrop Medical Crowdfunding: 499 Million Users Have Donated RMB74.7 Billion to 3.82 Million Patients

This quarter, Waterdrop Medical Crowdfunding continued to fulfill its role in providing emergency relief. Since its launch in 2016, approximately 499 million donors have cumulatively contributed RMB74.7 billion to 3.82 million patients with critical illnesses through Waterdrop Medical Crowdfunding.

Waterdrop Medical Crowdfunding has always practiced the philosophy of “tech for good,” building a dual safeguard system for case authenticity verification and transparent fund flow through AI technology. This quarter, Waterdrop Medical Crowdfunding introduced AI in risk management: relying on the semantic parsing capabilities of large models combined with strategic analysis, it built an intelligent identification matrix for multiple high-risk scenarios, precisely detecting dimensions such as fundraiser sensitive-identity recognition and abnormal assets. This has significantly improved the accuracy and efficiency of platform risk identification, ensuring the authenticity and reliability of fundraising cases.

In addition, Waterdrop Medical Crowdfunding has launched AI fundraising assistants in 548 cities nationwide. Leveraging intelligent, round-the-clock service, the assistants provide professional support to fundraising users across the country — especially those in remote areas and those unfamiliar with internet operations. Services cover end-to-end fundraising Q&A, basic critical-illness health education, and efficient fundraising guidance, making critical illness relief more precise and convenient and filling gaps left by human service coverage.

E-Find Platform: Q2 Revenue RMB35.2 Million, Partners with 255 Pharma Companies and CROs

Waterdrop’s digital clinical trial solutions business grew steadily, with E-Find Platform’s net revenue reaching RMB35.2 million, up 26.8% year-over-year. This quarter, E-Find Platform established partnerships with 255 well-known domestic and overseas pharma companies and CROs. As of June 30, 2026, it had cumulatively delivered 1,873 clinical trial projects with 17,052 enrolled patients.

In terms of social responsibility, in response to severe rainstorms and floods across multiple areas of Guangxi and debris-flow disasters at the Jilong Port in Jilong County, Shigatse, Tibet, Waterdrop urgently established a disaster relief emergency response team and quickly launched rescue operations. Waterdrop Charity immediately launched a “Relief” special section on its homepage and, in collaboration with multiple foundations, rushed aid to affected areas — delivering over 2,000 relief supply packages to the Guangxi disaster zone and doing its utmost to help affected communities through the crisis.

Shen Peng, Founder and CEO of Waterdrop Inc., said: “Waterdrop has always regarded technology as our core driver. With AI embedded across our platforms, we are well positioned to capture the growing demand in our existing businesses. In the future, we remain committed to delivering greater value for our shareholders in the years to come.”

AMAP Platform Showcases Spatial Intelligence at Qwen Conference Thailand 2026

By
Advertorial Desk
-
BANGKOK, THAILAND – Media OutReach Newswire – 8 September 2026 – On September 4, Qwen Conference Thailand 2026 was held in Bangkok, bringing together industry leaders, developers, AI creators, government organizations, universities, and technology partners to explore advances in AI and the future of AI-powered industries.

AMAP Platform, Alibaba’s global provider of spatial intelligence and location-based solutions, joined the conference to share its technologies and real-world applications in global location services and spatial intelligence with businesses and developers from Thailand and around the world.

At the event, AMAP Platform’s Head of Overseas Business presented the company’s global strategy for spatial intelligence and highlighted solutions across key industries, including two-wheeler mobility, logistics and delivery, and travel.

For two-wheeler mobility, AMAP Platform provides multilingual POI search, motorcycle route planning, restricted-road avoidance, ETA estimation, and navigation, helping businesses deliver smarter and more efficient mobility experiences.

For logistics and delivery, location services support key stages across the delivery lifecycle, from order planning and delivery operations to network optimization, helping businesses improve delivery efficiency and operational decision-making.

For travel, multilingual POI search, multimodal route planning, and real-time navigation support a seamless journey from destination discovery to on-the-go navigation.

AMAP Platform is also expanding spatial intelligence into a broader range of industries, including e-commerce and AIoT. Through standardized, easy-to-integrate location services, AMAP Platform enables businesses worldwide to embed mapping and spatial intelligence into their products and operations, unlocking new opportunities for business growth and AI-powered industry innovation.

Hashtag: #AMAPPlatform

The issuer is solely responsible for the content of this announcement.

Wuhan takes its cultural showcase abroad at Duisburg China Festival

By
Advertorial Desk
-

DUISBURG, GERMANY – Media OutRech Newswire – 8 September 2026 – The 2026 Duisburg China Festival kicked off here on Friday afternoon, with participation from some Chinese and German cities, aimed at strengthening ties between the two countries.

At the opening gala of the 2026 Duisburg China Festival, artists from the Wuhan Song and Dance Theatre performed the dance piece "White Clouds and Yellow Crane Are My Hometown."
At the opening gala of the 2026 Duisburg China Festival, artists from the Wuhan Song and Dance Theatre performed the dance piece “White Clouds and Yellow Crane Are My Hometown.”

The three-day festival features a wide range of cultural booths and interactive zones showcasing traditional Chinese cuisine, culture and contemporary art.

On Friday evening, top-tier performing arts troupes from Wuhan, capital city of central China’s Hubei Province, jointly staged the festival’s opening gala. Nearly 40 artists presented more than a dozen distinctive programs spanning Peking opera, Hanju opera, Chuju opera, acrobatics, and ethnic song and dance.

The Duisburg China Festival is a vivid expression of exchange between China and Germany, allowing Germans to experience and understand China up close, said Chang Haitao, acting consul general of the Chinese Consulate General in Dusseldorf.

In 1982, Duisburg and Wuhan became sister cities, the first of its kind between Germany and China. The two cities have maintained close people-to-people and economic exchanges, forging a bond between them ever since.

Impressed by the performance of the Chinese artists, Duisburg Mayor Soeren Link said that the opening gala was unforgettable for its standard, quality, richness, and the many different facets it presented.

Duisburg attaches great importance to its sister-city relationship with Wuhan and hopes to continue strengthening German-Chinese friendship as well as exchange and dialogue between the two sides, said Link.

Markus Teuber, commissioner for China affairs at the Mayor’s Office of Duisburg, said the rich array of theatrical, song and dance performances brought by Wuhan offered German audiences an excellent window into Chinese culture, and expressed hope that the two cities will continue to deepen cultural exchange in the future.

For Yang Jing, deputy director of the Wuhan Municipal Bureau of Culture and Tourism, the presence of Wuhan city at the festival “marks an important step in Wuhan culture’s global outreach.”

The Duisburg China Festival is an annual signature cultural event for the city, injecting fresh grassroots momentum into the development of German-Chinese friendship.

Hashtag: #DuisburgChinaFestival

The issuer is solely responsible for the content of this announcement.

HOYA Lens Singapore Launches MiYOSMART iQTF, Advancing Myopia Control for Children

By
Advertorial Desk
-

New-generation spectacle lens combines D.I.M.S. Technology with Triple Enhanced Design, with 9 out of 10 children showing no clinically relevant myopia progression* in the first 12 months of wear


SINGAPORE – Media OutRech Newswire – 8 September 2026 – HOYA Lens Singapore has launched MiYOSMART iQTF, introducing its most advanced myopia control spectacle lens and the latest evolution of its established MiYOSMART platform.

Newly launched in Singapore, MiYOSMART iQTF builds on MiYOSMART lenses, which feature Defocus Incorporated Multiple Segments (D.I.M.S.) Technology and are clinically proven to slow myopia progression by an average of 60%3. By combining D.I.M.S. Technology with the new Triple Enhanced Design (TED), MiYOSMART iQTF delivers greater myopia control effectiveness for children who need more.

In a randomised controlled clinical trial (RCT) of 196 schoolchildren in Hong Kong aged 4 to 12 years with myopia, 9 out of 10 children wearing MiYOSMART iQTF showed no clinically relevant myopia progression* in the first 12 months of wear1,2.

The findings underscore the importance of managing myopia early in childhood, particularly as myopia can progress during a child’s growing years. For parents, identifying and managing myopia early provides an opportunity to address its progression at a critical stage of a child’s development.

This is particularly important for children who develop myopia at a younger age. The clinical findings for MiYOSMART iQTF demonstrated myopia control efficacy in children as young as four years old for the first time with D.I.M.S. Technology-based spectacle lenses1. The research highlights the potential to manage early-onset myopia at a time when it can progress rapidly and the risk of longer-term impact is highest.

Myopia control spectacle lenses offer parents a non-invasive option for supporting their children’s myopia management while providing the vision correction they need for everyday activities. MiYOSMART iQTF builds on this approach with an enhanced spectacle lens design developed specifically to deliver stronger myopia control outcomes.

“At HOYA Vision Care, we imagine a world without myopia. This milestone is truly a generational leap in myopia control and represents an important step toward the vision we are committed to shaping for children around the world. Until today, no trial conducted on a myopia control spectacle lens has shown this level of effectiveness in controlling the condition,” said John Goltermann Lassen, CEO of HOYA Vision Care.

“Our mission is to improve life through vision by continuously raising the standard of care in myopia control, ensuring that thoughtful innovation and craftsmanship translate into meaningful clinical benefits for children and support eye care professionals’ practice.”

Triple Enhanced Design (TED): Activated, Powerful and Extended

MiYOSMART iQTF builds on D.I.M.S. Technology with Triple Enhanced Design (TED), featuring three key enhancements designed to drive greater myopia control effectiveness in children2:

Activated: Defocus segments are positioned closer to the geometric centre of the spectacle lens and are intended to continuously activate a “sweet spot”4 on the near-peripheral retina — referred to by HOYA as the Smart Zone† — identified by several studies as highly responsive to the myopic defocus signal that regulates myopia progression5,6.

Powerful: Higher defocus power delivers a stronger myopic defocus signal.

Extended: An extended treatment zone provides more extensive coverage of the child’s peripheral visual field, even with larger frames.

These enhancements build on the established D.I.M.S. Technology platform, with MiYOSMART iQTF representing the most advanced evolution of MiYOSMART, a technology backed by more than 100 peer-reviewed scientific publications7.

Options for Different Needs and Lifestyles

MiYOSMART iQTF is available in four options:

  • Clear
  • Clear with HOYA Full Control Coating
  • Chameleon Photochromic
  • Chameleon Photochromic with HOYA Full Control Coating

The Chameleon Photochromic options adapt to changing light conditions, darkening in sunlight to help reduce glare and fading back to clear indoors. This supports visual comfort as children move between classroom learning and outdoor activities, while providing protection against UV rays.

For added protection, HOYA Full Control Coating combines anti-reflective and scratch-resistant properties with blue light reduction, UV protection and an antibacterial treatment that helps limit bacterial growth on lens surfaces. Its water-, dirt- and dust-repellent properties also make the lenses easier to maintain during everyday wear.

With the introduction of MiYOSMART iQTF in Singapore, HOYA Vision Care continues to advance its myopia control portfolio through research, clinical evidence and spectacle lens innovation designed to support children and eye care professionals.

Learn more about MiYOSMART iQTF: https://www.hoyavision.com/sg/vision-products/myopia-management/miyosmart-iq/
Find an eyecare practitioner: https://www.hoyavision.com/sg/find-eye-care-practitioner/

Hear what other parents say about MiYOSMART: https://miyosmart.com.sg/

–END-

References:

*Outcomes for myopic children aged 4 to 12 years and may vary per age group and other parameters at the start of MiYOSMART iQTF treatment. Clinically relevant myopia progression is a change in cycloplegic spherical equivalent refraction of ≥-0.50D.

†“Smart Zone” is a marketing term used by HOYA when referring to a near-peripheral retinal zone shown to respond to myopic defocus. It is not a standard clinical or scientific term.

  1. Tse D.Y., Hon Y., Chun R. K., Leung T. W., Leung D. K. Y., To C. H., Lam C SY. Myopia Control Efficacy of Defocus Incorporated Multiple Segments Spectacle lens with Triple Enhanced Design: 12-month randomized controlled trial. Abstract 2523, ARVO 2026 Annual Meeting, Denver, USA. https://eppro02.ativ.me/web/index.php?page=IntHtml&project=ARVO26&id=4486941 (accessed date 03.04.2026).
  2. HOYA data on file. HOYA MiYOSMART iQTF spectacle lens clinical outcomes. 04/2026.
  3. Myopia progression (SER) by 59% and axial elongation (AL) decreased by 60% compared with those wearing SV lenses.Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019.
  4. Swiatczak B, et al. Retinal “sweet spot” for myopia treatment. Sci Rep. 2024;14:26773.
  5. HOYA data on file. MiYOSMART spectacle lens commercial data. 04/2026.
  6. Smith III EL, Arumugam B, Hung LF, et al. Eccentricity-dependent effects of simultaneous competing defocus on emmetropization in infant rhesus monkeys. Vision Res. 2020;177:32-40. DOI: 10.1016/j.visres. 2020.08.003.
  7. HOYA Vision Care. Confidence Through Evidence. 2026. Available from: https://www.hoyavision.com/vision-products/miyosmart/evidences/. (Accessed: 16.04.2026).

Hashtag: #visioncare #myopia #HOYAvisioncare #myopiasingapore #childmyopia

The issuer is solely responsible for the content of this announcement.

HOYA Vision Care

For over 60 years, HOYA Vision Care has been a global leader in the eyeglass lens industry. The company is dedicated to providing innovative vision care solutions for every stage of a patient’s life. With a presence in over 50 countries, HOYA Vision Care has a leading position in myopia management category and a proven expertise in advanced lens designs, high performance photochromic technologies and high-quality AR coatings. HOYA Vision Care’s solid market portfolio includes HOYA, Vision Ease, SEIKO and PENTAX optical lenses, as well as innovative products such as MiYOSMART myopia control lenses for children, Hoyalux iD MySelf individualized progressive lenses and the Sensity range of photochromic lenses. The company employs over 20,000 employees worldwide with large scale production facilities in Asia, Europe, and the US and 38 local Rx laboratories globally. For more information, please visit

About HOYA Corporation

Founded in 1941 in Tokyo, Japan, HOYA is a global technology and med-tech company, and a leading supplier of innovative high-tech and medical products. HOYA is active in the fields of healthcare and information technology, providing eyeglasses, medical endoscopes, intraocular lenses, optical lenses, as well as key components for semiconductor devices, LCD panels and HDDs. With over 150 offices and subsidiaries worldwide, HOYA currently employs a multinational workforce of over 35,000 people. For more information, please visit

Laos, Singapore Look to Forests, Farms for Carbon Finance

By
Thongsavanh Souvannasane
-
Laos' Minister of Agriculture and Environment Linkham Douangsavanh and Singapore’s Minister for Sustainability and the Environment and Ministerin-charge of Trade Relations Grace Fu sign an Implementation Agreement to collaborate on carbon credits under Article 6 of the Paris Agreement. 03 September 2026. (Photo: Singapore's Ministry of Trade and Industry)

Laos is moving to turn emissions reductions from forests, agriculture and other projects into a new source of foreign investment and climate funding, after signing a carbon-credit agreement with Singapore.

On 4 September, the two countries agreed to establish a legally binding framework that will let Laos generate and transfer carbon credits to Singapore under the Paris Agreement.

Laos holds one of the highest shares of forest cover in the region, and the government has set a target of raising that cover to 70 percent by 2035 as part of its national forestry strategy. 

Under the agreement, the countries will apply corresponding adjustments to their national greenhouse gas inventories to prevent double counting, ensuring each tonne of emissions reduction is claimed only once. 

Singapore will also channel 5 percent of proceeds from authorized carbon credit transactions toward climate adaptation in Laos. In addition, it will cancel 2 percent of authorized credits when they are first issued, meaning those credits cannot be sold, traded or counted toward any country’s emissions targets.

Laos will keep a share of the carbon credits generated through international projects. It can use those credits to help meet its climate targets , cutting emissions by 60 percent by 2030 and reaching net zero by 2050.

Under Laos’ 2025 carbon-credit rules, at least 10 percent of credits generated through international cooperation must stay in Laos. The rules also require carbon-credit payments and transactions to go through commercial banks or the Bank of Laos.

Why Laos Is Looking for Climate Finance

Climate change is costing Laos heavily. Monsoon floods and landslides caused more than USD 279 million in damage in 2024. More frequent floods, droughts and landslides are expected to put further pressure on the economy, which is already dealing with high debt and slow growth.

At the same time, Laos is preparing to graduate from least-developed-country status, meaning it will gradually lose access to some forms of concessional aid.

Carbon markets are one option. By selling carbon credits generated through projects such as forest protection, reforestation and sustainable agriculture, Laos can bring in outside investment while supporting rural communities and working toward its climate targets.

The government has been putting the rules and institutions in place. Laos is targeting net-zero emissions by 2050 and has introduced rules governing carbon credits, including how projects are approved, monitored and how revenues are shared.

The agreement with Singapore is a step toward putting those rules into practice and creating a market for Lao carbon credits.

Singapore’s Role

Singapore has been building itself into a regional hub for carbon trading and has signed similar agreements with several countries, including Thailand, Vietnam and the Philippines.

For Laos, the Singapore deal provides a potential route into the international carbon market, especially for projects in forests and agriculture.

Rainbow Opens Its First Store Digital Twin-Enabled Supermarket in Shenzhen

By
Advertorial Desk
-

SHENZHEN, China, Sept. 8, 2026 /PRNewswire/ — Rainbow, one of China’s leading omnichannel retailers, has opened its upgraded Shahe sp@ce supermarket in Shenzhen. Developed in collaboration with Hanshow and Rainbow’s technology subsidiary Lingzhi Digital Technology, the project marks Rainbow’s first Store Digital Twin implementation, bringing together real-time store visibility, decision support and operational execution within a live retail environment.


Operating a nationwide network of shopping centers, community retail centers and supermarkets, Rainbow has been exploring new ways to improve operational efficiency and customer experience. As Rainbow’s first Store Digital Twin-enabled project, the Shahe store brings data from connected IoT touchpoints into a unified digital representation, linking real-time sensing with analysis, decision-making and execution.

Reimagining a Longstanding Community Retail Destination

Located in Shenzhen’s Nanshan District, the Shahe sp@ce supermarket has served the local community for nearly 17 years. In 2026, the wider Shahe Rainbow development was upgraded into an urban lifestyle destination that brings together retail, dining, services and entertainment. The transformation reflects Rainbow’s broader ambition to expand the role of physical retail beyond transactions and create a more engaging destination for the surrounding community.

At the heart of the project is the newly opened sp@ce supermarket, built around Rainbow’s “City • Garden • Food Hall” concept, the supermarket features nine experiential areas designed around different food, lifestyle and community occasions. The store also incorporates Rainbow’s intelligent fulfilment center, supporting more efficient home-delivery services and strengthening the connection between in-store shopping and Rainbow’s broader omnichannel retail model.

As Rainbow’s first Store Digital Twin-enabled supermarket, the store brings together more than 17,000 IoT devices and AI capabilities to provide greater visibility into store conditions and support more timely operational decisions and actions.

Creating a More Connected Shopping Experience

At the Shahe sp@ce supermarket, digital technology is integrated throughout the shopping journey instead of being presented as a separate technology showcase.

Hanshow NexConnect Smart Cart, integrated with Lingzhi’s proprietary AI shopping assistant, serves as a digital companion throughout the shopping journey, providing shoppers with easy access to product information, in-store navigation, promotional offers, and available checkout services. By giving shoppers greater visibility over their purchases and streamlining key shopping activities, it helps create a more convenient and efficient shopping experience.

At the shelf edge, Hanshow Nebular Ultra Electronic Shelf Labels support centimeter-level product positioning, serving as a key component of the Store Digital Twin infrastructure. The tap-to-interact functionality extends the ESL from a price display medium into an interactive service touchpoint. With a simple tap, shoppers can access product details, traceability information, usage guidance and promotional content.

Together, these customer-facing touchpoints help connect products, content and services at the right moment and location, bringing digital capabilities into real shopping scenarios and creating a more intuitive shopper engagement throughout the customer journey.

Turning Store Visibility into Operational Action

Beyond customer-facing applications, the Store Digital Twin is designed to support day-to-day store operations.

In shelf management scenarios, Hanshow combines Electronic Shelf Labels, Location Intelligence, AI Vision and robotics technologies to support out-of-shelf identification, merchandising management and shelf execution. These capabilities help retailers gain greater visibility into shelf conditions and product availability while improving execution across the sales floor.

Leveraging its proprietary Bailingniao retail AI model, Lingzhi Digital Technology contributes digital capabilities that support sales forecasting, replenishment strategies, task management and decision support, helping store teams make more informed decisions and respond more effectively to day-to-day operational needs.

By connecting store visibility with timely action, the project moves store digitalization beyond simply recording what has happened. When store conditions can be identified and addressed more quickly, shoppers benefit from more timely product availability and a smoother shopping experience. Store associates can also focus more of their attention on tasks that require judgement, communication, and customer service.

Advancing Store Digital Twin Innovation in Live Retail Environments

As retailers worldwide seek to improve efficiency while managing complex store environments, the ability to translate operational visibility into timely action is becoming increasingly important. The Shahe project demonstrates how Store Digital Twin capabilities can be deployed in a live retail environment to connect sensing, analysis, decision-making, execution and continuous optimization within a unified operating model.

“Our goal with sp@ce 3.0 is to create a better everyday shopping experience built on quality, freshness, transparency and trust,” said Xiao Zhanglin, Chairman of Rainbow Digital Commercial. “As Rainbow’s first Store Digital Twin-enabled store, the Shahe sp@ce supermarket brings digital visibility into day-to-day operations, helping our teams respond faster and more accurately, while allowing store employees to spend more time on the service and experiences that matter to customers.”

“The true value of technology lies in helping retailers operate more effectively and creating a more natural experience for shoppers,” said Relvin Sun, Dean of Hanshow Retail Research Institute. “Through our collaboration with Rainbow and Lingzhi Digital Technology, we are bringing together intelligent store infrastructure, retail AI and operational expertise to support daily store operations and customer experience, while continuing to strengthen Hanshow’s Store Digital Twin capabilities through real-world retail applications.”

For Hanshow, the project represents an important milestone in the development of its Store Digital Twin ecosystem. Working alongside Rainbow and Lingzhi Digital Technology, Hanshow will continue exploring how digital store technologies can support practical retail applications, helping retailers improve operational agility and customer experience.

GCCL Strengthens Asia-Pacific Presence at Asia Bio Partnering Forum 2026

By
Advertorial Desk
-

YONGIN, South Korea , Sept. 8, 2026 /PRNewswire/ — GCCL (Global Clinical Central Lab), a South Korea-based leading provider of clinical trial sample analysis, announced its participation as a Platinum Sponsor at Asia Bio Partnering Forum 2026 (ABP 2026), held in Singapore from August 31 to September 2.

Through a series of partnering meetings with global pharmaceutical and biotechnology companies, contract research organizations (CROs) and regional stakeholders, GCCL explored opportunities to expand its clinical sample analysis and assay development services across the Asia-Pacific region.

The company engaged with drug developers working across a broad range of therapeutic modalities, including mRNA and nucleic acid therapeutics, radiopharmaceuticals and antibody-based therapies. These discussions focused on evolving analytical requirements in global clinical development and potential opportunities for collaboration.

GCCL also met with executives from global CROs and Singapore-based pharmaceutical, diagnostics and clinical trial service companies to discuss existing partnerships and opportunities for further collaboration. In addition, the company engaged with a Singapore government-affiliated economic development organization to explore ways to support local biotech companies and strengthen connections within the regional life sciences ecosystem.

As a Platinum Sponsor, GCCL sponsored the official ABP 2026 Welcome Reception. Yoo-Hwa Choi, Head of Business Operations at GCCL, delivered welcome remarks and highlighted the company’s capabilities in clinical sample analysis and its commitment to supporting global drug development.

At its exhibition booth, GCCL showcased its integrated Central Lab, Bioanalytical Lab and R&D Lab capabilities, which support clinical development from early- through late-stage trials. The company also held partnering discussions with pharmaceutical and biotechnology companies and related organizations from Korea, China, Japan, Singapore, Vietnam and Europe.

“ABP 2026 provided an important opportunity to engage directly with drug developers and global partners across the Asia-Pacific region and better understand their evolving analytical needs across increasingly diverse therapeutic modalities,” said Yoo-Hwa Choi, Head of Business Operations at GCCL. “We will continue to build on these relationships and expand collaboration with global CROs and regional biotech companies as we strengthen GCCL’s role as a trusted clinical development partner in Asia-Pacific.”

ABP 2026 brought together approximately 650 pharmaceutical and biotechnology industry professionals, investors and life sciences stakeholders, with approximately 2,500 one-on-one partnering meetings held during the event.

About GCCL (Global Clinical Central Lab)

GCCL, a subsidiary of the GC Group, is a leading clinical trial sample analysis provider offering an integrated “one-stop lab solution” with central, bioanalysis, and BSL-3 labs under one system. With tailored solutions, GCCL delivers precise and efficient analytical services across all phases of clinical trials, solidifying its position as a trusted partner in new drug development. Leveraging advanced platforms and LIMS, the company supports partners across Asia and beyond with customized and compliant solutions. In recognition of its leadership, GCCL recently received Frost & Sullivan’s 2025 Best Practices Customer Value Leadership Award in the Asia-Pacific clinical sample analysis services industry. For more details, visit: www.eng.gccl.co.kr.

GC Corporation Contacts (Media)

Sohee Kim
shkim20@gccorp.com

Yelin Jun
yelin@gccorp.com

Yoonjae Na
yjy6520@gccorp.com

1...345...6,501Page 4 of 6,501